CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance

SIMPLE SUMMARY: Drug resistance is an obstacle to cancer therapy, and the underlying mechanisms are still being explored. CC chemokine ligand-2 (CCL2) is one of the key proinflammatory chemokines that regulate the migration and infiltration of multiple inflammatory cells, such as monocytes and macro...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Zhenbo, Tu, Jian, Ying, Ying, Diao, Yunlian, Zhang, Ping, Liao, Shu, Xiong, Zhijuan, Huang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454502/
https://www.ncbi.nlm.nih.gov/pubmed/36077785
http://dx.doi.org/10.3390/cancers14174251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454502/
https://www.ncbi.nlm.nih.gov/pubmed/36077785
http://dx.doi.org/10.3390/cancers14174251

Ejemplares similares